CompletedPhase 1

The Effect of Colchicine on Platelet Function Profiles in Patients With Stable Coronary Artery Disease

Trinidad and Tobago22 participantsStarted 2024-08-21

Plain-language summary

The effects of colchicine on cardiovascular health in patients with stable coronary artery disease have been shown to be beneficial due to its anti-inflammatory properties. This present study aims to explore the effects of colchicine on platelet reactivity in patients with coronary artery disease on dual antiplatelet therapy.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with stable coronary artery disease. * Patients older than 18 years of age. * Patients currently on dual anti platelets, aspirin and clopidogrel Exclusion Criteria: • Patients already on colchicine

What they're measuring

P2Y12 reaction units and Aspirin reaction units

Timeframe: two weeks

Trial details

NCT IDNCT06567678

SponsorThe University of The West Indies

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-10-20

View on ClinicalTrials.gov More Coronary Artery Disease trials